pharmaceutical industry

Supported by
Ad image
Supported by
Ad image

Serbia’s Pharmaceutical Industry Shifts Towards Growth

Serbia's pharmaceutical sector is experiencing a significant transition, evolving from a focus on defensive healthcare supply to becoming a growth-oriented industry. This change is driven by various factors, including rising public healthcare demand, an ageing population, increased consumption of prescription medications, reliance on imports, potential for regional exports, and renewed investments in manufacturing. In the first quarter of 2026, Serbia's exports of medicinal and pharmaceutical products reached €172.3 million, marking a year-on-year increase of 15.7%. Conversely, imports totaled €520.0 million,…

Supported by
Ad image

Promote Your Business Where Decisions Are Made

Reach a relevant business audience in Serbia and the region through sponsored articles, banner advertising, and targeted visibility on serbian.news.
error: Content is protected !!